Polyelectrolyte Complexes for CNS Polypeptide Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The delivery of polypeptides to the central nervous system (CNS) is hindered by factors such as instability, sequestration by tissues, and the presence of the blood-brain barrier, limiting the effectiveness of therapeutic agents.
Innovation Solution
Development of polyelectrolyte complexes comprising a polypeptide and a synthetic polymer, with a charge ratio of at least 2, which enhances stability, retention, and brain uptake by forming a complex that can be administered intranasally to bypass the blood-brain barrier.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If polypeptides are administered directly to the CNS, then therapeutic effect is achieved, but delivery is hindered by instability, tissue sequestration, and the blood-brain barrier
Solution Approach 1:
The patent uses polyelectrolyte complexes as intermediary carriers to transport polypeptides across the blood-brain barrier. The complex comprises a polypeptide and a synthetic polymer with opposite charge, forming a stable conjugate that can be delivered intranasally to bypass the blood-brain barrier and achieve effective CNS delivery
Solution Approach 2:
The invention creates a composite material system by combining the polypeptide (therapeutic agent) with a synthetic polyelectrolyte polymer to form a polyelectrolyte complex. This composite structure leverages the properties of both components: the therapeutic activity of the polypeptide and the delivery-enhancing properties of the polymer, including improved stability and barrier penetration
2Reliability
If polypeptides are administered to the CNS, then therapeutic effect is achieved, but instability of administered polypeptides limits effectiveness
Solution Approach 1:
The polypeptide is combined with a synthetic polyelectrolyte polymer to form a stable composite structure (polyelectrolyte complex). This composite material protects the polypeptide from degradation while maintaining its therapeutic activity, thereby improving both stability and effectiveness
Solution Approach 2:
The patent modifies the physical and chemical parameters of the polypeptide by forming a complex with a charged polymer. This changes the stability parameters of the polypeptide, protecting it from enzymatic degradation and improving its half-life in vivo while maintaining delivery capability
3Reliability
If polypeptides are administered to the CNS, then therapeutic effect is achieved, but sequestration by tissues reduces delivery efficiency
Solution Approach 1:
The polyelectrolyte complex acts as an intermediary vehicle that prevents direct interaction between the polypeptide and tissue sequestration sites. The polymer carrier protects the polypeptide from being sequestered by tissues during delivery, ensuring more efficient transport to the target CNS location
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The polyelectrolyte complexes improve the delivery and retention of therapeutic agents in the CNS, reducing efflux and increasing brain uptake, thereby effectively treating CNS disorders.
Implementation Method 1
a complex comprising a therapeutic polypeptide and a synthetic polymer comprising at least one charge opposite to the charge of the therapeutic polypeptide
Data Source
AI summary
The present invention relates to compositions and methods for the delivery of agents to a subject, particularly to the central nervous system (CNS).